US2010286367A1PendingUtilityA1

Conjugates of soluble peptidic compounds with membrane-binding agents

55
Assignee: ADPROTECH LTDPriority: Jul 15, 1996Filed: Aug 15, 2008Published: Nov 11, 2010
Est. expiryJul 15, 2016(expired)· nominal 20-yr term from priority
A61P 7/02C07C 323/59A61P 29/00A61K 47/64C12N 9/6462A61K 47/54A61K 38/00C07C 323/41C12Y 304/21073C07K 14/3153C07K 14/70596C07K 16/28
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides, among other things, soluble derivatives of soluble polypeptides that incorporate membrane binding elements. Methods of making these soluble derivatives, and methods of using these soluble derivatives also are provided.

Claims

exact text as granted — not AI-modified
1 - 49 . (canceled) 
     
     
         50 . A membrane localization reagent for directing a molecule to an outer membrane of a cell, wherein the membrane localization reagent is soluble and comprises:
 (a) at least one lipophilic binding element comprising aliphatic acyl groups;   (b) a hydrophilic peptide binding element comprising basic amino acids, wherein the hydrophilic binding element is bound to the lipophilic element; and   (c) a linker that covalently binds (i) the molecule to be directed to the outer membrane of a cell to (ii) the hydrophilic peptide binding element of the membrane localization reagent.   
     
     
         51 . The membrane localization reagent of  claim 50 , wherein the hydrophilic peptide binding element comprises lysine residues. 
     
     
         52 . The membrane localization reagent of  claim 51 , wherein the hydrophilic peptide binding element comprises three to ten lysine residues. 
     
     
         53 . The membrane localization reagent of  claim 51 , wherein the hydrophilic peptide binding element comprises four to seven lysine residues. 
     
     
         54 . The membrane localization reagent of  claim 50 , wherein the hydrophilic peptide binding element comprises arginine residues. 
     
     
         55 . The membrane localization reagent of  claim 54 , wherein the hydrophilic peptide binding element comprises three to ten arginine residues. 
     
     
         56 . The membrane localization reagent of  claim 55 , wherein the hydrophilic peptide binding element comprises four to seven arginine residues. 
     
     
         57 . A membrane localization reagent for directing a molecule to an outer membrane of a cell, wherein the membrane localization reagent is soluble and comprises a hydrophilic peptide binding element, wherein the peptide comprises a sequence selected from the group consisting of: 
       
         
           
                 
                 
                 
               
                     
                   (a) DGPKKKKKKSPSKSSG; 
                   (SEQ ID NO. 8) 
                 
                     
                 
                     
                   (b) GSSKSPSKKKKKKPGD; 
                   (SEQ ID NO. 9) 
                 
                     
                 
                     
                   (c) SPSNETPKKKKKRFSFKKSG; 
                   (SEQ ID NO. 10) 
                 
                     
                 
                     
                   (d) DGPKKKKKKSPSKSSK; 
                   (SEQ ID NO. 11) 
                 
                     
                   and 
                     
                 
                     
                 
                     
                   (e) SKDGKKKKKKSKTK. 
                   (SEQ ID NO. 12) 
                 
             
                
                
                
                
                
                
                
                
                
                
               
            
           
         
       
     
     
         58 . The membrane localization reagent of  claim 57 , wherein the hydrophilic peptide binding element comprises GSSKSPSKKKKKKPGD (SEQ ID NO. 9). 
     
     
         59 . The membrane localization reagent of  claim 50 , wherein the lipophilic binding element comprises 8 to 18 methylene units. 
     
     
         60 . The membrane localization reagent of  claim 59 , wherein the lipophilic binding element comprises 10 to 14 methylene units. 
     
     
         61 . The membrane localization reagent of  claim 58 , wherein the membrane localization reagent comprises a lipophilic binding element, and wherein the lipophilic binding element comprises myristoyl. 
     
     
         62 . The membrane localization reagent of  claim 60 , wherein the lipophilic binding element comprises myristoyl. 
     
     
         63 . The membrane localization reagent according to  claim 50 , wherein the linker is selected from the group consisting of a cysteine residue; an N-haloacetyl group (where halo signifies chlorine, bromine or iodine); a haloacetyl group (where halo signifies chlorine, bromine or iodine) at an 6-amino group of a lysine residue; a bond; an amide group at the C-terminus; an N-terminal blocking group; and a fatty acid N-acyl group at the N-terminus or at an E-amino group of a lysine residue. 
     
     
         64 . The membrane localization reagent according to  claim 50 , wherein the molecule is a therapeutic agent. 
     
     
         65 . The soluble compound according to  50 , wherein the linker is selected from the group consisting of a cysteine residue; an N-haloacetyl group (where halo signifies chlorine, bromine or iodine); a haloacetyl group (where halo signifies chlorine, bromine or iodine) at an ε-amino group of a lysine residue; a bond; an amide group at the C-terminus; an N-terminal blocking group; and a fatty acid N-acyl group at the N-terminus or at an ε-amino group of a lysine residue. 
     
     
         66 . A soluble derivative of a soluble polypeptide, wherein said derivative consisting of a conjugate or fusion of the polypeptide with a unit further consisting of two or more covalently linked heterologous membrane binding elements which elements are not all identical, which are capable of interacting independently with components of cellular or artificial membranes exposed to extracellular fluids and which are selected from the group consisting of:
 a) a membrane-insertive hydrophobic group selected from aliphatic acyl groups with between 8 and 18 methylene units and aliphatic amines with between 8 and 18 methylene units;   b) a membrane-associative charged peptide consisting of between 3 and 25 amino acids of which no less than 2 and no more than 12 are basic residues; and   c) a membrane component ligand further consisting of a peptide containing between 3 and 13 amino acids derived from known ligands for membrane components such as transmembrane proteins and identified by screening of chemical, bacteriophage, or other displayed libraries against specific membrane-derived molecular targets.   
     
     
         67 . A soluble derivative of a soluble polypeptide according to  claim 66 , wherein the basic residues comprise lysine. 
     
     
         68 . A soluble derivative of a soluble polypeptide according to  claim 66 , wherein the membrane-associative charged peptide comprises basic amino acids; and other amino acids selected from the group consisting of Serine, Threonine, Glycine, Proline, Alanine, Cysteine, Aspartic Acid, Glutamic Acid, Asparagine, and Glutamine. 
     
     
         69 . A soluble derivative of a soluble polypeptide according to  claim 66 , wherein the membrane-associative charged peptide comprises lysine.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.